title: Improving effects of epigallocatechin-3-gallate on hemorheological abnormalities of aging Guinea pigs.
abstract: BACKGROUND
  Epigallocatechin-3-gallate (EGCG) is the most potent antioxidant of all the green tea catechins. The objective of the present study was to find out whether it improved the age-induced hemorheological abnormalities or not.
  
  
  RESULTS
  Twenty-four-month-old aging guinea pigs were used to test the effects of EGCG on hemorheological properties. Orally feeding EGCG at 30 mg x kg(-1) x day (-1) for 28 days resulted in a decrease in erythrocyte membrane malondialdehyde, and further improved erythrocyte deformability and blood viscosity at high and middle shear rates. In addition, it also significantly reduced erythrocyte aggregation, and improved blood viscosity at low shear rates and viscoelasticity at oscillatory flow. Consequently, efficiency of blood oxygen transport in aged guinea pigs increased after administration with EGCG.
  
  
  CONCLUSIONS
  Orally feeding EGCG 30 mg x kg(-1) x day(-1) for 28 days significantly improves the abnormal hemorheological parameters. These results suggest that EGCG has considerable potential as a substantial component for the development of new drugs or functional foods in improving the age-induced hemorheological abnormalities.
authors: Department of Ophthalmology, Mackay Memorial Hospital and Mackay Medicine, Nursing and Management College, Taichung, Taiwan.
authors: Huey-Chuan
authors: HC
authors: Cheng
authors: Chi-Ming
authors: CM
authors: Chan
authors: Hsin-Sheng
authors: HS
authors: Tsay
authors: Hong-Jen
authors: HJ
authors: Liang
authors: Yu-Chih
authors: YC
authors: Liang
authors: Der-Zen
authors: DZ
authors: Liu
mesh_terms: D000284:Administration, Oral; D000375:Aging / Q000097:blood*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects*; D002392:Catechin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D004907:Erythrocyte Deformability / Q000187:drug effects*; D004910:Erythrocyte Membrane / Q000378:metabolism; D006168:Guinea Pigs; D008315:Malondialdehyde / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D011897:Random Allocation
chemical_list: D000975:Antioxidants; D008315:Malondialdehyde; D002392:Catechin; C045651:epigallocatechin gallate; D010100:Oxygen